Note: Ingredients listed on restricted chemical lists
EC/CAS
201-173-7/79-06-1
Name of the chemical
Acrylamide
Concentration
>=50-<60
General Information
Version
1.2
Revision date
2024-07-22
Product name
Ageflex ACM50 monomer
1.2.1 Relevant identified uses
Monomer
Emergency telephone
+1-302-502-0991, +431 406 43
Icons in SDS
Company Information
company name
Solenis Netherlands B.V
e-mail address of the competent person responsible for the Safety Data Sheet
EHSProductSafetyTeam@solenis.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302+H332, H315, H317, H319, H340, H350, H361f, H372
Hazard statements
Code
Statements
H302+H332
Harmful if swallowed or if inhaled
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger
Hazard statements
H302 + H332 Harmful if swallowed or if inhaled. H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H340 May cause genetic defects. H350 May cause cancer. H361f Suspected of damaging fertility. H372 Causes damage to organs (Peripheral nervous system) through prolonged or repeated exposure.
Prevention
P201 Obtain special instructions before use. P260 Do not breathe mist or vapours. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response
P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor if you feel unwell. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Hazardous Ingredients
acrylamide
Additional information
Restricted to professional users
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Acute toxicity, Category 4 H302: Harmful if swallowed. Acute toxicity, Category 4 H332: Harmful if inhaled. Skin irritation, Category 2 H315: Causes skin irritation. Eye irritation, Category 2 H319: Causes serious eye irritation. Skin sensitisation, Category 1 H317: May cause an allergic skin reaction. Germ cell mutagenicity, Category 1B H340: May cause genetic defects. Carcinogenicity, Category 1B H350: May cause cancer. Reproductive toxicity, Category 2 H361f: Suspected of damaging fertility. Specific target organ toxicity - repeated H372: Causes damage to organs through exposure, Category 1, Peripheral nervous prolonged or repeated exposure. system